Waters Corporation Announces CEO Transition Plan - - BioPharm International

ADVERTISEMENT

Waters Corporation Announces CEO Transition Plan



Waters Corporation announced that Douglas A. Berthiaume will retire as CEO within the next two years.

The company’s board of directors has appointed a succession planning committee that will guide the process of selecting a successor and plans to hire an executive search firm to assist in a search, which will consider both internal and external candidates.

Berthiaume, who is 64, was appointed president and CEO of Waters Corporation in 1994 when the business was separated from Millipore, and assumed the additional role of chairman in 1996.

Source: Waters Corporation

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Author Guidelines

Click here